Review: taking Prednisone and Neurontin together


Summary

Drug interactions are reported among people who take Prednisone and Neurontin together. This review analyzes the effectiveness and drug interactions between Prednisone and Neurontin. It is created by eHealthMe based on reports of 10,775 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Prednisone

Prednisone has active ingredients of prednisone. It is often used in rheumatoid arthritis. (latest outcomes from Prednisone 224,210 users)

Neurontin

Neurontin has active ingredients of gabapentin. It is often used in pain. (latest outcomes from Neurontin 76,477 users)

On Sep, 20, 2016

10,775 people who take Prednisone, Neurontin are studied.


Number of reports submitted per year:

Prednisone and Neurontin drug interactions.

Drug effectiveness over time:

Prednisone:
  • < 1 month: 14.0% - (3 of 21 people)
  • 1 - 6 months: 20.0% - (5 of 24 people)
  • 6 - 12 months: 75.0% - (3 of 4 people)
  • 1 - 2 years: 57.0% - (4 of 7 people)
  • 2 - 5 years: 41.0% - (7 of 17 people)
  • 5 - 10 years: 75.0% - (9 of 12 people)
  • 10+ years: 50.0% - (3 of 6 people)
  • not specified: 0.0% - (0 of 1 people)
Neurontin:
  • < 1 month: 26.0% - (4 of 15 people)
  • 1 - 6 months: 11.0% - (2 of 17 people)
  • 6 - 12 months: 7.0% - (1 of 13 people)
  • 1 - 2 years: 23.0% - (4 of 17 people)
  • 2 - 5 years: 22.0% - (4 of 18 people)
  • 5 - 10 years: 33.0% - (3 of 9 people)
  • 10+ years: 33.0% - (1 of 3 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Prednisone:
  • female: 36.0% - (27 of 75 people)
  • male: 41.0% - (7 of 17 people)
Neurontin:
  • female: 21.0% - (16 of 75 people)
  • male: 17.0% - (3 of 17 people)

Drug effectiveness by age:

Prednisone:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 1 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 14.0% - (1 of 7 people)
  • 30-39: 25.0% - (3 of 12 people)
  • 40-49: 17.0% - (3 of 17 people)
  • 50-59: 42.0% - (9 of 21 people)
  • 60+: 52.0% - (18 of 34 people)
Neurontin:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 1 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 14.0% - (1 of 7 people)
  • 30-39: 0.0% - (0 of 11 people)
  • 40-49: 23.0% - (4 of 17 people)
  • 50-59: 33.0% - (8 of 24 people)
  • 60+: 18.0% - (6 of 32 people)

Most common drug interactions over time *:

< 1 month:
  • gastroenteritis viral
  • anaemia
  • thrombocytopenia
  • nausea
  • pain
  • aspartate aminotransferase increased
  • alanine aminotransferase increased
  • myelodysplastic syndrome
  • pyrexia
  • dehydration
1 - 6 months:
  • cellulitis
  • anaemia
  • abdominal pain
  • fatigue
  • hidradenitis
  • neutropenia
  • weakness
  • drug ineffective
  • pneumonia
  • infective exacerbation of chronic obstructive airways disease
6 - 12 months:
  • anaemia
  • fall
  • insomnia
  • urinary tract infection
  • muscular weakness
  • nausea
  • oedema peripheral
  • pain in extremity
  • pneumonia
  • renal failure chronic
1 - 2 years:
  • joint pain
  • cellulitis
  • hypothyroidism postoperative
  • dizziness
  • cerebrovascular accident
  • asthenia
  • pulmonary embolism
  • dysstasia
  • eye swelling
  • eyelid oedema
2 - 5 years:
  • anxiety
  • depression
  • suicide attempt
  • pain
  • hives
  • itching
  • pulmonary embolism
  • rash generalised
  • urticaria
  • chest pain
5 - 10 years:
  • anxiety
  • asthma
  • atrial fibrillation
  • depression
  • edema - peripheral, peripheral edema
  • intentional overdose
  • suicide attempt
  • vascular calcification
  • weight decreased
  • emotional distress
10+ years:
  • cellulitis
  • joint pain
  • hypothyroidism postoperative
  • fall
  • hypoaesthesia
  • nephrogenic systemic fibrosis
  • weight decreased
  • gait disturbance
  • hypokinesia
  • nerve compression
not specified:
  • pain
  • anxiety
  • nausea
  • fatigue
  • arthralgia
  • dyspnoea
  • pneumonia
  • back pain
  • fall
  • pain in extremity

Most common drug interactions by gender *:

female:
  • pain
  • nausea
  • arthralgia
  • fatigue
  • fall
  • anxiety
  • dyspnoea
  • pain in extremity
  • headache
  • pneumonia
male:
  • pain
  • anxiety
  • pneumonia
  • anaemia
  • dyspnoea
  • fatigue
  • back pain
  • arthralgia
  • asthenia
  • osteonecrosis of jaw

Most common drug interactions by age *:

0-1:
  • orthostatic hypotension
  • blood cholesterol increased
  • gallbladder operation
  • sensation of foreign body
  • type 2 diabetes mellitus
  • chest pain
  • dizziness
  • dysphonia
  • gastrointestinal haemorrhage
  • headache
2-9:
  • lymphopenia
  • alanine aminotransferase increased
  • aspartate aminotransferase increased
  • gamma-glutamyltransferase increased
  • adenovirus infection
  • hepatic steatosis
  • convulsion
  • gastroenteritis viral
  • heart rate increased
  • hepatitis infectious
10-19:
  • crohn's disease
  • gastroenteritis
  • arthritis
  • impaired gastric emptying
  • pain
  • weight increased
  • abdominal pain
  • dehydration
  • haematemesis
  • drug ineffective
20-29:
  • pain
  • arthralgia
  • dyspnoea
  • vomiting
  • drug ineffective
  • pain in extremity
  • nausea
  • weight decreased
  • pyrexia
  • oedema peripheral
30-39:
  • nausea
  • pain
  • anxiety
  • arthralgia
  • oedema peripheral
  • dyspnoea
  • fatigue
  • pain in extremity
  • abdominal pain
  • back pain
40-49:
  • pain
  • nausea
  • anxiety
  • arthralgia
  • fatigue
  • headache
  • dyspnoea
  • oedema peripheral
  • pain in extremity
  • anaemia
50-59:
  • pain
  • fatigue
  • anxiety
  • arthralgia
  • nausea
  • headache
  • anaemia
  • depression
  • fall
  • pyrexia
60+:
  • pain
  • pneumonia
  • fall
  • anxiety
  • dyspnoea
  • back pain
  • anaemia
  • nausea
  • arthralgia
  • fatigue

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Prednisone and Neurontin?

Can you answer these questions?

More questions for: Prednisone, Neurontin

You may be interested in these reviews

More reviews for: Prednisone, Neurontin

On eHealthMe, Prednisone (prednisone) is often used to treat rheumatoid arthritis. Neurontin (gabapentin) is often used to treat pain. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.